Phase I Trial of in Situ Vaccination with Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined with Pembrolizumab for Advanced NSCLC

被引：0
作者：
Liu, B. [1 ]
Lisberg, A. [1 ]
Salehi-Rad, R. [1 ]
Lee, J. M. [1 ]
Tran, L. M. [1 ]
Krysan, K. [1 ]
Li, R. [1 ]
Lim, R. J. [1 ]
Dumitras, C. [1 ]
Jing, Z. [1 ]
Abtin, F. [1 ]
Suh, R. D. [1 ]
Genshaft, S. J. [1 ]
Oh, S. [1 ]
Aberle, D. R. [1 ]
Winter, L. E. [1 ]
Sharma, S. [1 ]
Elashoff, D. [1 ]
Garon, E. B. [1 ]
Dubinett, S. M. [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A33
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 26 条
  • [21] Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
    Juan Hernando
    Tjoung-Won Park
    Kirsten Kübler
    Ruth Offergeld
    Harald Schlebusch
    Thomas Bauknecht
    Cancer Immunology, Immunotherapy, 2002, 51 : 45 - 52
  • [22] VACCINATION OF CLL PATIENTS WITH AUTOLOGOUS DENDRITIC CELLS LOADED WITH APOPTOTIC BODIES (APO-DC): A PHASE I-II CLINICAL TRIAL
    Palma, M.
    Hansson, L.
    Adamson, L.
    Eriksson, I.
    Nasman-Glaser, B.
    Widen, K.
    Choudhury, A. R.
    Osterborg, A.
    Mellstedt, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 164 - 164
  • [23] Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
    Lee, Jay M.
    Lee, Mi-Heon
    Garon, Edward
    Goldman, Jonathan W.
    Salehi-Rad, Ramin
    Baratelli, Felicita E.
    Schaue, Dorthe
    Wang, Gerald
    Rosen, Fran
    Yanagawa, Jane
    Walser, Tonya C.
    Lin, Ying
    Park, Stacy J.
    Adams, Sharon
    Marincola, Francesco M.
    Tumeh, Paul C.
    Abtin, Fereidoun
    Suh, Robert
    Reckamp, Karen L.
    Lee, Gina
    Wallace, William D.
    Lee, Sarah
    Zeng, Gang
    Elashoff, David A.
    Sharma, Sherven
    Dubinett, Steven M.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4556 - 4568
  • [24] Phase I/II randomized trial of GM.CD40L vaccine plus/minus CCL21 in advanced lung adenocarcinoma: Final results.
    Gray, Jhanelle Elaine
    Chiappori, Alberto
    Williams, Charles C.
    Tanvetyanon, Tawee
    Haura, Eric B.
    Creelan, Ben C.
    Devane, Rebecca D.
    Smilee, Renee
    Noyes, David
    Kim, Jongphil
    Antonia, Scott Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] Therapeutic vaccination against advanced pancreatic cancer by autologous dendritic cells pulsed with a MUC1 peptide: Preclinical results of a clinical phase I trial
    Jin, D.
    Rong, Y.
    Lou, W.
    Qin, X.
    Wu, W.
    Nin, X.
    Nin, X.
    Wang, D.
    Kuang, T.
    Qin, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] A Phase I/II Study of Vaccination By Autologous Leukemic Apoptotic Corpse Pulsed Dendritic Cells for Elderly Acute Myeloid Leukemia Patients in First or Second Complete Remission (LAM DC trial)
    Chevallier, Patrice
    Saiagh, Soraya
    Dehame, Virginie
    Guillaume, Thierry
    Peterlin, Pierre
    Garnier, Alice
    Le Bris, Yannick
    Bercegeay, Sylvain
    Coulais, Delphine
    Rambaud, Marie-Aude
    Bossard, Celine
    Stocco, Veronique
    Dreno, Brigitte
    Juge-Morineau, Nadine
    Moreau, Philippe
    Bene, Marie-Christine
    Gregoire, Marc
    BLOOD, 2016, 128 (22)
123